Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR)

CUSIP: 92764N102

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
159,231,812
Total 13F shares
86,118,572
Share change
-873,629
Total reported value
$2,179,650,166
Put/Call ratio
49%
Price per share
$25.31
Number of holders
219
Value change
-$15,704,818
Number of buys
107
Number of sells
97

Quarterly Holders Quick Answers

What is CUSIP 92764N102?
CUSIP 92764N102 identifies VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) as of Q4 2022

As of 31 Dec 2022, Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) was held by 219 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 86,118,572 shares. The largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, BlackRock Inc., VANGUARD GROUP INC, Temasek Holdings (Private) Ltd, STATE STREET CORP, BAILLIE GIFFORD & CO, ALLIANCEBERNSTEIN L.P., Bill & Melinda Gates Foundation, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY. This page lists 219 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.